Thank you for downloading this publication. Please let us know why you chose this publication:

Why are you interested in this publication?

to learn about best practicesto inform programme designto research/find data and evidence on an issueto find policy recommendationsother

What organisation do you represent?

donor agencygovernmentNGOprivate sectora UN agencyresearch institute/academiastudentMalaria ConsortiumYou will only need to complete this form once per browser/deviceother

How do you prefer to read or receive publications?

printscreen

Subscribe to the Malaria Consortium newsletter (optional)

Email:ContinueWe may contact you for feedback on the publication you have downloaded. If you do not want to be contacted, please leave the email field blank. Your information will never be shared with any third party.

Share this page

Latest news

Article

Malaria Consortium placed as a GiveWell top charity

GiveWell is a world-renowned meta-NGO that recommends charities by assessing them on four criteria: effectiveness, cost-effectiveness, transparency, and room for more funding. In order for any charity to receive a GiveWell recommendation, it must undergo a rigorous and extensive assessment process, and it is necessary to be the most qualified at the interventions focused on. GiveWell stated that Malaria Consortium is “an organization that we feel offers donors an outstanding opportunity to accomplish good with their donations."

Through our expertise in delivering seasonal malaria chemoprevention (SMC) programmes, our progress in eliminating malaria has been recognised as among the most effective worldwide. SMC is a highly effective intervention providing protection for children under five living in the Sahel, who are the most vulnerable to the disease. SMC involves administering up to four monthly doses of preventive antimalarial drugs to children aged three to 59 months during peak transmission in the rainy season. Since it was approved by the World Health Organization in 2012, SMC has been found to prevent up to 75 percent of malaria cases.

Our ACCESS-SMC project is focused on helping national malaria control programmes to scale up SMC coverage, providing technical, logistical and financial support. We bring extensive experience and tested models of delivery, of strengthening national drug supply chains, and supporting delivery of SMC to beneficiaries.

We are very pleased to have received this recognition of excellence, and look forward to working with GiveWell and their partners.